Biocon Boosts Biosimilar Portfolio with YESINTEK Market Approvals
Biocon Boosts Biosimilar Portfolio with YESINTEK Market Approvals
Clinical studies showed that Yesintek is a biosimilar to Stelara and has similar pharmacokinetic, safety, efficacy and immunogenicity profile compared with Stelara. Yesintek…
Read More...
Read More...